# | Pathway | Proteins |
---|
1 | Carbon metabolism (no map in kegg database) | ENSBTAP00000017392-D1, ENSP00000414662-D1, ENSBTAP00000033696-D1, ENSBTAP00000052439-D3, ENSBTAP00000027941-D1, ENSP00000331897-D1, ENSBTAP00000009923-D1, ENSBTAP00000007982-D1, ENSBTAP00000004431-D1, ENSBTAP00000037577-D6, ENSP00000345771-D1, ENSBTAP00000005730-D1, ENSP00000403265-D1, ENSP00000359991-D1, ENSP00000362413-D2, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1, ENSBTAP00000008907-D1, ENSBTAP00000027348-D1, ENSP00000229270-D1, ENSP00000378669-D1 |
2 | Biosynthesis of amino acids (no map in kegg database) | ENSBTAP00000017392-D1, ENSP00000331897-D1, ENSBTAP00000037577-D6, ENSP00000345771-D1, ENSBTAP00000005730-D1, ENSP00000403265-D1, ENSP00000359991-D1, ENSP00000362413-D2, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1, ENSBTAP00000008907-D1, ENSBTAP00000027348-D1, ENSP00000229270-D1, ENSP00000378669-D1 |
3 | Hypertrophic cardiomyopathy (HCM) | ENSP00000343009-D1, ENSBTAP00000019704-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSBTAP00000053653-D7, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000350667-D1, ENSP00000350667-D3, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSBTAP00000050318-D1, ENSP00000306099-D1, ENSBTAP00000023373-D1, ENSP00000306361-D1 |
4 | Dilated cardiomyopathy | ENSP00000343009-D1, ENSBTAP00000019704-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSBTAP00000053653-D7, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000350667-D1, ENSP00000350667-D3, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSBTAP00000030521-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSBTAP00000050318-D1, ENSBTAP00000017182-D1, ENSP00000306099-D1, ENSBTAP00000023373-D1, ENSP00000306361-D1 |
5 | Thyroid hormone signaling pathway | ENSBTAP00000019704-D1, ENSBTAP00000053653-D7, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSBTAP00000013169-D1, ENSP00000345771-D1, ENSBTAP00000008132-D2, ENSBTAP00000009406-D1, ENSBTAP00000017182-D1, ENSP00000306099-D1, ENSBTAP00000010351-D1, ENSP00000306361-D1 |
6 | Glycine, serine and threonine metabolism | ENSBTAP00000017392-D1, ENSBTAP00000033696-D1, ENSBTAP00000001383-D1, ENSP00000359991-D1, ENSBTAP00000008907-D1 |
7 | Cardiac muscle contraction | ENSP00000317159-D1, ENSBTAP00000019704-D1, ENSP00000306397-D1, ENSBTAP00000053653-D7, ENSBTAP00000013169-D1, ENSP00000350667-D1, ENSP00000350667-D3 |
8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ENSP00000343009-D1, ENSBTAP00000019704-D1, ENSP00000369129-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSBTAP00000050318-D1, ENSBTAP00000049867-D3, ENSP00000306099-D1, ENSBTAP00000023373-D1, ENSP00000306361-D1 |
9 | Amyotrophic lateral sclerosis (ALS) | ENSP00000405382-D2, ENSP00000293190-D1, ENSBTAP00000027941-D1, ENSBTAP00000014883-D1, ENSP00000357076-D4, yakG038520 |
10 | Focal adhesion | ENSP00000343009-D1, ENSBTAP00000024902-D1, ENSBTAP00000015668-D1, ENSP00000211998-D1, ENSP00000420213-D1, ENSP00000357076-D4, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSBTAP00000015248-D2, ENSBTAP00000049867-D3, ENSP00000306099-D1, ENSP00000358879-D1, ENSP00000327145-D1, ENSP00000306361-D1 |
11 | 2-Oxocarboxylic acid metabolism (no map in kegg database) | ENSP00000331897-D1, ENSBTAP00000005730-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1, ENSBTAP00000027348-D1 |
12 | Arginine biosynthesis | ENSBTAP00000009923-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
13 | Tyrosine metabolism | ENSBTAP00000001383-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
14 | Phenylalanine metabolism | ENSBTAP00000001383-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
15 | Legionellosis | ENSP00000405382-D2, ENSP00000310226-D1, ENSBTAP00000017497-D1, ENSP00000364805-D5, ENSBTAP00000022979-D1, ENSBTAP00000019970-D1, ENSP00000339053-D13, ENSP00000306099-D1, ENSP00000306361-D1 |
16 | Mineral absorption | ENSBTAP00000013169-D1, ENSBTAP00000009564-D1, ENSBTAP00000001704-D2, ENSBTAP00000002023-D1 |
17 | Fat digestion and absorption | ENSBTAP00000026345-D1, ENSBTAP00000023750-D1, ENSBTAP00000009440-D1, ENSBTAP00000038799-D1 |
18 | Glucagon signaling pathway | ENSBTAP00000052439-D3, ENSBTAP00000015277-D1, ENSP00000216962-D1, ENSP00000395337-D3, ENSP00000345771-D1, ENSP00000403265-D1, ENSP00000359991-D1 |
19 | Osteoclast differentiation | ENSBTAP00000001440-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSBTAP00000012837-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSBTAP00000010351-D1, ENSP00000306361-D1 |
20 | Glycolysis / Gluconeogenesis | ENSBTAP00000033696-D1, ENSBTAP00000052439-D3, ENSP00000395337-D3, ENSBTAP00000037577-D6, ENSP00000345771-D1, ENSP00000403265-D1, ENSP00000359991-D1, ENSP00000362413-D2, ENSP00000229270-D1, ENSP00000378669-D1 |
21 | Regulation of actin cytoskeleton | ENSP00000343009-D1, ENSBTAP00000024902-D1, ENSBTAP00000015668-D1, ENSP00000211998-D1, ENSP00000357076-D4, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000022979-D1, ENSBTAP00000020512-D4, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSBTAP00000015248-D2, ENSBTAP00000049867-D3, ENSP00000306099-D1, ENSBTAP00000006465-D4, ENSP00000379613-D3, ENSP00000306361-D1 |
22 | Central carbon metabolism in cancer | ENSBTAP00000052439-D3, ENSP00000331897-D1, ENSP00000395337-D3, ENSP00000345771-D1, ENSP00000403265-D1, ENSP00000359991-D1, ENSBTAP00000027348-D1 |
23 | Citrate cycle (TCA cycle) | ENSP00000414662-D1, ENSBTAP00000033696-D1, ENSBTAP00000052439-D3, ENSP00000331897-D1, ENSBTAP00000007982-D1, ENSBTAP00000005730-D1, ENSBTAP00000027348-D1 |
24 | Malaria | ENSBTAP00000050256-D2, ENSBTAP00000051337-D10, ENSP00000346839-D1, ENSP00000260356-D1, ENSBTAP00000022979-D1, ENSBTAP00000023750-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
25 | HIF-1 signaling pathway | ENSBTAP00000052439-D3, ENSP00000395337-D3, ENSBTAP00000037577-D6, ENSP00000345771-D1, ENSBTAP00000009564-D1, ENSP00000362413-D2, ENSBTAP00000001704-D2, ENSP00000378669-D1 |
26 | Leukocyte transendothelial migration | ENSBTAP00000024902-D1, ENSBTAP00000015668-D1, ENSP00000211998-D1, ENSP00000357076-D4, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000022979-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000015248-D2, ENSBTAP00000049867-D3, ENSP00000306099-D1, ENSP00000306361-D1 |
27 | p53 signaling pathway | ENSP00000405382-D2, ENSP00000260356-D1, ENSBTAP00000009715-D1 |
28 | Alanine, aspartate and glutamate metabolism | ENSBTAP00000009923-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
29 | Metabolic pathways (no map in kegg database) | ENSP00000317159-D1, ENSP00000405382-D2, ENSBTAP00000017392-D1, ENSP00000414662-D1, ENSBTAP00000033696-D1, ENSBTAP00000052439-D3, ENSBTAP00000001383-D1, ENSBTAP00000015277-D1, ENSP00000384262-D1, ENSP00000268668-D1, ENSP00000306397-D1, ENSP00000331897-D1, ENSP00000216962-D1, ENSP00000392709-D1, ENSP00000285093-D1, ENSP00000376894-D1, ENSP00000304592-D1, ENSBTAP00000007701-D1, ENSBTAP00000009923-D1, ENSP00000304006-D1, ENSP00000395337-D3, ENSBTAP00000007982-D1, ENSBTAP00000037577-D6, ENSBTAP00000017710-D1, ENSP00000345771-D1, ENSBTAP00000005730-D1, ENSP00000217426-D1, ENSP00000265132-D1, ENSP00000403265-D1, ENSP00000359991-D1, ENSBTAP00000040330-D1, ENSP00000362413-D2, ENSBTAP00000004079-D1, ENSBTAP00000006383-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1, ENSBTAP00000008907-D1, ENSBTAP00000027348-D1, ENSP00000229270-D1, ENSP00000378669-D1 |
30 | Complement and coagulation cascades | ENSBTAP00000006167-D1, ENSBTAP00000005713-D1, ENSP00000265023-D1, ENSBTAP00000018574-D1, ENSP00000384420-D1, ENSBTAP00000022979-D1, ENSBTAP00000023309-D1, ENSBTAP00000009798-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSBTAP00000004927-D1, ENSBTAP00000042856-D1, ENSP00000306361-D1 |
31 | Bile secretion | ENSBTAP00000023552-D1, ENSBTAP00000013169-D1 |
32 | Phenylalanine, tyrosine and tryptophan biosynthesis | ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
33 | Pathogenic Escherichia coli infection | ENSBTAP00000041398-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000329165-D3, ENSP00000260356-D1, ENSBTAP00000009158-D3, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000047883-D15, ENSBTAP00000032779-D3, ENSBTAP00000001988-D1, ENSBTAP00000021529-D4 |
34 | Protein processing in endoplasmic reticulum | ENSBTAP00000017497-D1, ENSP00000324173-D1, ENSP00000368186-D4, ENSBTAP00000014883-D1, ENSP00000357076-D4, ENSP00000378294-D1, yakG038520, ENSP00000364805-D5, ENSBTAP00000002508-D1, ENSBTAP00000019970-D1, ENSP00000299767-D1, ENSBTAP00000040330-D1, ENSP00000300289-D1 |
35 | Proteoglycans in cancer | ENSBTAP00000024902-D1, ENSP00000384262-D1, ENSBTAP00000015668-D1, ENSP00000420213-D1, ENSP00000357076-D4, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSP00000358879-D1, ENSP00000327145-D1, ENSP00000306361-D1 |
36 | ECM-receptor interaction | ENSP00000343009-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000023750-D1, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
37 | Toxoplasmosis | ENSP00000405382-D2, ENSBTAP00000017497-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000364805-D5, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000010351-D1 |
38 | MAPK signaling pathway | ENSBTAP00000017497-D1, ENSBTAP00000014883-D1, ENSP00000420213-D1, ENSP00000357076-D4, yakG038520, ENSP00000364805-D5, ENSP00000410452-D1, ENSP00000358879-D1, ENSP00000327145-D1 |
39 | Influenza A | ENSP00000405382-D2, ENSBTAP00000017497-D1, ENSP00000412582-D1, ENSP00000364805-D5, ENSP00000360671-D2, ENSBTAP00000008132-D2, ENSBTAP00000010351-D1 |
40 | Pertussis | ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000384420-D1, ENSBTAP00000022979-D1, ENSBTAP00000020512-D4, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSP00000306099-D1, ENSBTAP00000042856-D1, ENSP00000306361-D1 |
41 | Thyroid hormone synthesis | ENSP00000324173-D1, ENSBTAP00000013169-D1, ENSP00000299767-D1 |
42 | Small cell lung cancer | ENSP00000405382-D2, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000265132-D1 |
43 | Non-alcoholic fatty liver disease (NAFLD) | ENSP00000317159-D1, ENSP00000405382-D2, ENSP00000268668-D1, ENSP00000306397-D1, ENSP00000392709-D1, ENSBTAP00000014883-D1, ENSP00000357076-D4, yakG038520 |
44 | Bacterial invasion of epithelial cells | ENSBTAP00000024902-D1, ENSBTAP00000015668-D1, ENSP00000269122-D1, ENSP00000211998-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1 |
45 | Vitamin digestion and absorption | ENSBTAP00000026345-D1, ENSBTAP00000038799-D1 |
46 | Neuroactive ligand-receptor interaction | ENSP00000293190-D1, ENSBTAP00000009406-D1 |
47 | Proximal tubule bicarbonate reclamation | ENSBTAP00000009923-D1, ENSBTAP00000013169-D1 |
48 | Adrenergic signaling in cardiomyocytes | ENSBTAP00000019704-D1, ENSBTAP00000053653-D7, ENSBTAP00000013169-D1, ENSP00000350667-D1, ENSP00000350667-D3, ENSBTAP00000017182-D1 |
49 | Glyoxylate and dicarboxylate metabolism | ENSBTAP00000033696-D1, ENSBTAP00000027941-D1, ENSBTAP00000005730-D1 |
50 | Salivary secretion | ENSBTAP00000050833-D29, ENSBTAP00000016986-D1, ENSBTAP00000013169-D1 |
51 | Leishmaniasis | ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000022979-D1, ENSP00000363827-D1, ENSBTAP00000030521-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSP00000306099-D1, ENSBTAP00000010351-D1, ENSP00000306361-D1 |
52 | Phagosome | ENSBTAP00000041398-D1, ENSBTAP00000037042-D1, ENSBTAP00000015668-D1, ENSP00000265062-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000009158-D3, ENSBTAP00000022979-D1, ENSBTAP00000023750-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSBTAP00000030521-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000047883-D15, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
53 | MicroRNAs in cancer | ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000350667-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSP00000410452-D1, ENSP00000306361-D1 |
54 | PI3K-Akt signaling pathway | ENSP00000343009-D1, ENSP00000368186-D4, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000030521-D1, ENSP00000300527-D1, ENSP00000299767-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSBTAP00000032779-D3, ENSP00000306361-D1 |
55 | Salmonella infection | ENSP00000265062-D1, ENSP00000420213-D1, ENSBTAP00000008132-D2, ENSP00000358879-D1, ENSBTAP00000006465-D4, ENSP00000327145-D1, ENSP00000379613-D3 |
56 | Alzheimer's disease | ENSP00000317159-D1, ENSP00000405382-D2, ENSP00000293190-D1, ENSBTAP00000019704-D1, ENSP00000268668-D1, ENSP00000306397-D1, ENSP00000392709-D1, ENSBTAP00000037577-D6, ENSBTAP00000017710-D1, ENSBTAP00000013354-D1 |
57 | cAMP signaling pathway | ENSP00000293190-D1, ENSBTAP00000019704-D1, ENSP00000357076-D4, ENSBTAP00000013169-D1, ENSBTAP00000017182-D1, ENSBTAP00000015248-D2 |
58 | Shigellosis | ENSBTAP00000015668-D1, ENSP00000211998-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000006465-D4 |
59 | Fatty acid biosynthesis | ENSP00000304592-D1 |
60 | Protein export | ENSP00000324173-D1 |
61 | Nicotine addiction | ENSP00000293190-D1 |
62 | D-Glutamine and D-glutamate metabolism | ENSBTAP00000009923-D1 |
63 | ABC transporters | ENSBTAP00000023552-D1 |
64 | Nitrogen metabolism | ENSBTAP00000009923-D1 |
65 | Pyruvate metabolism | ENSBTAP00000033696-D1, ENSBTAP00000052439-D3, ENSP00000395337-D3, ENSP00000403265-D1 |
66 | Viral myocarditis | ENSP00000405382-D2, ENSBTAP00000037042-D1, ENSBTAP00000053653-D7, ENSP00000346839-D1, ENSBTAP00000022979-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSBTAP00000030521-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
67 | Platelet activation | ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
68 | Peroxisome | ENSBTAP00000027941-D1, ENSP00000331897-D1, ENSBTAP00000027348-D1 |
69 | Huntington's disease | ENSP00000317159-D1, ENSP00000405382-D2, ENSP00000268668-D1, ENSP00000269122-D1, ENSP00000306397-D1, ENSP00000392709-D1, ENSP00000355330-D1, ENSBTAP00000017710-D1, ENSP00000360671-D2 |
70 | Fatty acid metabolism (no map in kegg database) | ENSP00000285093-D1, ENSP00000304592-D1 |
71 | cGMP-PKG signaling pathway | ENSBTAP00000019704-D1, ENSBTAP00000053653-D7, ENSBTAP00000013169-D1, ENSP00000360671-D2, ENSBTAP00000017182-D1, ENSBTAP00000015248-D2 |
72 | Herpes simplex infection | ENSP00000405382-D2, ENSBTAP00000037042-D1, ENSBTAP00000014883-D1, ENSBTAP00000022979-D1, ENSBTAP00000010351-D1 |
73 | Hepatitis B | ENSP00000405382-D2, ENSP00000363827-D1, ENSBTAP00000032779-D3, ENSBTAP00000010351-D1 |
74 | Cysteine and methionine metabolism | ENSP00000395337-D3, ENSP00000217426-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
75 | Protein digestion and absorption | ENSBTAP00000015668-D1, ENSBTAP00000013169-D1, ENSP00000300527-D1, ENSP00000265132-D1 |
76 | Antigen processing and presentation | ENSBTAP00000017497-D1, ENSBTAP00000037042-D1, ENSP00000324173-D1, ENSP00000368186-D4, ENSP00000364805-D5, ENSP00000300289-D1 |
77 | Propanoate metabolism | ENSBTAP00000033696-D1, ENSP00000395337-D3, ENSBTAP00000007982-D1 |
78 | Insulin resistance | ENSBTAP00000015277-D1, ENSP00000216962-D1, ENSBTAP00000023750-D1 |
79 | Fructose and mannose metabolism | ENSP00000345771-D1, ENSP00000229270-D1, ENSP00000378669-D1 |
80 | AMPK signaling pathway | ENSP00000304592-D1, ENSBTAP00000005581-D1, ENSP00000345771-D1, ENSBTAP00000023750-D1, ENSBTAP00000044443-D1 |
81 | Parkinson's disease | ENSP00000317159-D1, ENSP00000405382-D2, ENSP00000268668-D1, ENSP00000306397-D1, ENSP00000392709-D1, ENSBTAP00000017710-D1, ENSP00000360671-D2 |
82 | Rap1 signaling pathway | ENSBTAP00000015668-D1, ENSP00000357076-D4, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000022979-D1, ENSP00000363827-D1, ENSBTAP00000008132-D2, ENSP00000300527-D1, ENSP00000265132-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSBTAP00000006465-D4, ENSP00000306361-D1 |
83 | Staphylococcus aureus infection | ENSP00000329165-D3, ENSBTAP00000022979-D1, ENSBTAP00000030521-D1, ENSBTAP00000009798-D1, ENSP00000306099-D1, ENSBTAP00000001988-D1, ENSBTAP00000042856-D1, ENSP00000306361-D1 |
84 | Endocrine and other factor-regulated calcium reabsorption | ENSP00000269122-D1, ENSBTAP00000013169-D1 |
85 | NOD-like receptor signaling pathway | ENSP00000368186-D4, ENSP00000299767-D1 |
86 | Tryptophan metabolism | ENSP00000414662-D1, ENSBTAP00000027941-D1 |
87 | Prolactin signaling pathway | ENSBTAP00000003409-D1, ENSBTAP00000010351-D1 |
88 | Oxytocin signaling pathway | ENSBTAP00000005581-D1, ENSBTAP00000014306-D5, ENSBTAP00000008132-D2, ENSBTAP00000015248-D2 |
89 | Measles | ENSBTAP00000017497-D1, ENSP00000364805-D5, ENSBTAP00000030521-D1, ENSBTAP00000010351-D1 |
90 | Estrogen signaling pathway | ENSBTAP00000017497-D1, ENSP00000368186-D4, ENSP00000364805-D5, ENSP00000299767-D1 |
91 | Spliceosome | ENSBTAP00000022514-D25, ENSBTAP00000017497-D1, ENSP00000412582-D1, yakG032579, ENSP00000364805-D5, ENSP00000338095-D1, ENSBTAP00000022514-D11 |
92 | Tight junction | ENSBTAP00000053653-D7, ENSBTAP00000020395-D1, ENSP00000284770-D1, ENSBTAP00000008132-D2, ENSBTAP00000015248-D2, ENSBTAP00000049867-D3, ENSP00000379613-D3 |
93 | Cell adhesion molecules (CAMs) | ENSBTAP00000037042-D1, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000022979-D1, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000265132-D1, ENSP00000306099-D1, ENSP00000395463-D14, ENSP00000306361-D1 |
94 | Hematopoietic cell lineage | ENSBTAP00000037042-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSBTAP00000023750-D1, ENSBTAP00000030521-D1, ENSBTAP00000009406-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
95 | Gap junction | ENSBTAP00000041398-D1, ENSBTAP00000009158-D3, ENSBTAP00000047883-D15 |
96 | Glutathione metabolism | ENSP00000331897-D1, ENSP00000335620-D3, ENSBTAP00000027348-D1 |
97 | Arginine and proline metabolism | ENSBTAP00000004079-D1, ENSBTAP00000009440-D1, ENSBTAP00000015873-D1 |
98 | Inositol phosphate metabolism | ENSP00000229270-D1 |
99 | Carbohydrate digestion and absorption | ENSBTAP00000013169-D1 |
100 | Fatty acid elongation | ENSP00000285093-D1 |
101 | Inflammatory bowel disease (IBD) | ENSBTAP00000010351-D1 |
102 | Vascular smooth muscle contraction | ENSBTAP00000014306-D5, ENSP00000224784-D2, ENSBTAP00000015248-D2, ENSP00000379613-D3 |
103 | Pathways in cancer | ENSP00000405382-D2, ENSP00000368186-D4, ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000335620-D3, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000299767-D1, ENSP00000265132-D1, ENSBTAP00000010351-D1 |
104 | Calcium signaling pathway | ENSP00000293190-D1, ENSBTAP00000019704-D1, ENSP00000360671-D2, ENSBTAP00000030521-D1, ENSBTAP00000017182-D1 |
105 | Oxidative phosphorylation | ENSP00000317159-D1, ENSP00000268668-D1, ENSP00000306397-D1, ENSP00000392709-D1, ENSBTAP00000017710-D1 |
106 | Hippo signaling pathway | ENSBTAP00000022979-D1, ENSBTAP00000008132-D2, ENSP00000306099-D1, ENSBTAP00000032779-D3, ENSP00000306361-D1 |
107 | Gastric acid secretion | ENSBTAP00000013169-D1, ENSBTAP00000008132-D2 |
108 | Hippo signaling pathway - fly | ENSBTAP00000008132-D2, ENSBTAP00000032779-D3 |
109 | Starch and sucrose metabolism | ENSBTAP00000015277-D1, ENSP00000216962-D1 |
110 | Pancreatic secretion | ENSBTAP00000019704-D1, ENSBTAP00000013169-D1 |
111 | TNF signaling pathway | ENSBTAP00000014883-D1, ENSP00000357076-D4, yakG038520 |
112 | Viral carcinogenesis | ENSBTAP00000037042-D1, ENSBTAP00000013453-D5, ENSBTAP00000024902-D1, ENSP00000375736-D1, ENSBTAP00000022979-D1, ENSP00000403265-D1, ENSBTAP00000049867-D3, ENSBTAP00000032779-D3 |
113 | PPAR signaling pathway | ENSP00000284770-D1, ENSBTAP00000053003-D4, ENSBTAP00000022375-D1, ENSBTAP00000023750-D1 |
114 | Neurotrophin signaling pathway | ENSBTAP00000014883-D1, ENSP00000357076-D4, yakG038520, ENSBTAP00000017863-D1 |
115 | Axon guidance | ENSBTAP00000015668-D1, ENSP00000355330-D1, ENSP00000346839-D1, ENSBTAP00000006923-D1, ENSP00000260356-D1, ENSBTAP00000020512-D4, ENSP00000363827-D1, ENSP00000300527-D1, ENSP00000265132-D1 |
116 | Toll-like receptor signaling pathway | ENSBTAP00000006923-D1, ENSBTAP00000010351-D1 |
117 | Valine, leucine and isoleucine degradation | ENSBTAP00000033696-D1, ENSP00000285093-D1 |
118 | Chemokine signaling pathway | ENSBTAP00000024902-D1, ENSP00000357076-D4, ENSBTAP00000010351-D1 |
119 | Prostate cancer | ENSP00000368186-D4, ENSP00000335620-D3, ENSP00000299767-D1 |
120 | Glycosaminoglycan degradation | ENSP00000384262-D1 |
121 | Cocaine addiction | ENSP00000293190-D1 |
122 | Sulfur metabolism | ENSP00000405382-D2 |
123 | Drug metabolism - cytochrome P450 | ENSP00000335620-D3 |
124 | Ether lipid metabolism | ENSP00000304006-D1 |
125 | Adipocytokine signaling pathway | ENSBTAP00000023750-D1 |
126 | Phototransduction - fly | ENSBTAP00000008132-D2 |
127 | Renin-angiotensin system | ENSP00000367697-D1 |
128 | Insulin signaling pathway | ENSBTAP00000015277-D1, ENSP00000216962-D1, ENSP00000304592-D1, ENSP00000284770-D1 |
129 | Natural killer cell mediated cytotoxicity | ENSBTAP00000037042-D1, ENSP00000357076-D4, ENSBTAP00000022979-D1, ENSBTAP00000030521-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
130 | B cell receptor signaling pathway | ENSP00000357076-D4, ENSBTAP00000030521-D1, ENSBTAP00000012837-D1 |
131 | Purine metabolism | ENSP00000376894-D1, ENSP00000403265-D1 |
132 | Pentose phosphate pathway | ENSP00000345771-D1, ENSP00000378669-D1 |
133 | Adherens junction | ENSP00000211998-D1, ENSBTAP00000014883-D1, ENSP00000284770-D1, yakG038520, ENSBTAP00000008132-D2, ENSBTAP00000049867-D3 |
134 | Amoebiasis | ENSP00000211998-D1, ENSP00000265062-D1, ENSP00000346839-D1, ENSBTAP00000022979-D1, ENSBTAP00000030521-D1, ENSBTAP00000049867-D3, ENSP00000306099-D1, ENSP00000306361-D1 |
135 | N-Glycan biosynthesis | ENSBTAP00000040330-D1 |
136 | Chemical carcinogenesis | ENSP00000335620-D3 |
137 | Metabolism of xenobiotics by cytochrome P450 | ENSP00000335620-D3 |
138 | Vibrio cholerae infection | ENSBTAP00000008132-D2 |
139 | Aldosterone-regulated sodium reabsorption | ENSBTAP00000013169-D1 |
140 | Lysine degradation | ENSP00000414662-D1 |
141 | Amphetamine addiction | ENSP00000293190-D1 |
142 | Fatty acid degradation | ENSP00000285093-D1 |
143 | Jak-STAT signaling pathway | ENSBTAP00000010351-D1 |
144 | Bladder cancer | ENSP00000260356-D1 |
145 | Pyrimidine metabolism | ENSP00000376894-D1 |
146 | Cell cycle | ENSBTAP00000032779-D3 |
147 | African trypanosomiasis | ENSBTAP00000050256-D2, ENSBTAP00000051337-D10, ENSBTAP00000030521-D1 |
148 | Galactose metabolism | ENSBTAP00000007701-D1, ENSP00000345771-D1 |
149 | Primary immunodeficiency | ENSBTAP00000037042-D1, ENSP00000374847-D1, ENSBTAP00000030521-D1, ENSBTAP00000048809-D1 |
150 | Rheumatoid arthritis | ENSBTAP00000022979-D1, ENSBTAP00000030521-D1, ENSP00000306099-D1, ENSP00000306361-D1 |
151 | Sphingolipid signaling pathway | ENSBTAP00000014883-D1, ENSP00000357076-D4, yakG038520 |
152 | Hepatitis C | ENSBTAP00000010351-D1 |
153 | Synaptic vesicle cycle | ENSP00000269122-D1 |
154 | Insulin secretion | ENSBTAP00000013169-D1 |
155 | Progesterone-mediated oocyte maturation | ENSP00000368186-D4 |
156 | Apoptosis | ENSP00000405382-D2 |
157 | T cell receptor signaling pathway | ENSBTAP00000037042-D1, ENSP00000357076-D4 |
158 | Systemic lupus erythematosus | ENSBTAP00000013453-D5, ENSP00000375736-D1, ENSBTAP00000022979-D1, ENSBTAP00000030521-D1, ENSBTAP00000049867-D3, ENSBTAP00000042856-D1 |
159 | Alcoholism | ENSP00000293190-D1, ENSBTAP00000013453-D5, ENSP00000375736-D1 |
160 | HTLV-I infection | ENSBTAP00000037042-D1, ENSBTAP00000022979-D1, ENSP00000360671-D2, ENSP00000306099-D1, ENSP00000306361-D1 |
161 | Tuberculosis | ENSP00000405382-D2, ENSP00000265062-D1, ENSBTAP00000022979-D1, ENSBTAP00000030521-D1, ENSP00000306099-D1, ENSBTAP00000010351-D1, ENSP00000306361-D1 |
162 | Intestinal immune network for IgA production | ENSP00000346839-D1, ENSBTAP00000030521-D1 |
163 | mRNA surveillance pathway | ENSP00000412582-D1 |
164 | FoxO signaling pathway | ENSBTAP00000027941-D1 |
165 | Graft-versus-host disease | ENSBTAP00000037042-D1 |
166 | Type II diabetes mellitus | ENSP00000403265-D1 |
167 | Type I diabetes mellitus | ENSBTAP00000037042-D1 |
168 | Glutamatergic synapse | ENSP00000293190-D1 |
169 | Long-term potentiation | ENSP00000293190-D1 |
170 | TGF-beta signaling pathway | ENSP00000260356-D1 |
171 | Pancreatic cancer | ENSBTAP00000010351-D1 |
172 | Ribosome | ENSBTAP00000037200-D1, ENSBTAP00000038763-D5, ENSBTAP00000003962-D1 |
173 | Epstein-Barr virus infection | ENSBTAP00000017497-D1, ENSBTAP00000037042-D1, ENSP00000346839-D1, ENSP00000364805-D5, ENSBTAP00000030521-D1, ENSBTAP00000032779-D3 |
174 | Autoimmune thyroid disease | ENSBTAP00000037042-D1, ENSBTAP00000030521-D1 |
175 | Allograft rejection | ENSBTAP00000037042-D1, ENSBTAP00000030521-D1 |
176 | Transcriptional misregulation in cancer | ENSBTAP00000013453-D5, ENSP00000346839-D1, ENSBTAP00000030521-D1 |
177 | beta-Alanine metabolism | ENSBTAP00000001383-D1 |
178 | Choline metabolism in cancer | ENSP00000284770-D1 |
179 | Arachidonic acid metabolism | ENSP00000265132-D1 |
180 | RNA degradation | ENSP00000345771-D1 |
181 | Prion diseases | ENSBTAP00000017497-D1, ENSP00000324173-D1, ENSP00000364805-D5 |
182 | Fc epsilon RI signaling pathway | ENSP00000357076-D4, ENSBTAP00000030521-D1 |
183 | Circadian entrainment | ENSP00000293190-D1 |
184 | Chagas disease (American trypanosomiasis) | ENSBTAP00000022979-D1 |
185 | Colorectal cancer | ENSP00000405382-D2 |
186 | Vasopressin-regulated water reabsorption | ENSBTAP00000017863-D1 |
187 | Oocyte meiosis | ENSBTAP00000032779-D3 |
188 | Endocytosis | ENSBTAP00000017497-D1, ENSBTAP00000037042-D1, ENSP00000269122-D1, ENSP00000265062-D1, ENSBTAP00000002174-D3, ENSP00000364805-D5 |
189 | Fc gamma R-mediated phagocytosis | ENSP00000357076-D4, ENSBTAP00000020512-D4, ENSBTAP00000030521-D1 |
190 | NF-kappa B signaling pathway | ENSBTAP00000030521-D1 |
191 | Asthma | ENSBTAP00000030521-D1 |
192 | VEGF signaling pathway | ENSBTAP00000024902-D1 |
193 | RNA transport | ENSP00000412582-D1, ENSP00000339053-D13 |
194 | Proteasome | ENSP00000271308-D1 |
195 | Lysosome | ENSP00000269122-D1, ENSP00000388762-D1, ENSBTAP00000003073-D1 |
196 | Phospholipase D signaling pathway | ENSBTAP00000030521-D1 |